GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ
CMAJ - April 4, 2000JAMC - le 4 avril 2000

Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice [Correction]

CMAJ 2000;162:973

In the article by Jaime Caro and colleagues on anticoagulation for patients with atrial fibrillation,1 it was stated in the introduction that "warfarin is being prescribed for only about two-thirds of patients with atrial fibrillation." In fact, the 5 articles that the authors cited to support that estimate report rates that vary between 32% and 40%. The authors regret this inadvertent misrepresentation of the reported rates.

The online version is correct.

Reference

  1. Caro JJ, Flegel KM, Orejuela ME, Kelley HE, Speckman JL, Migliaccio-Walle K. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice. CMAJ 1999;161(5):493-7.

© 2000 Canadian Medical Association or its licensors